Raia Drogasil (OTCMKTS:RADLY) and Maplebear (NASDAQ:CART) Head to Head Survey

Raia Drogasil (OTCMKTS:RADLY – Get Free Report) and Maplebear (NASDAQ:CART – Get Free Report) are both consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Institutional & Insider Ownership

63.1% of Maplebear shares are held by institutional investors. 24.0% of Maplebear shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations and price targets for Raia Drogasil and Maplebear, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Raia Drogasil 0 1 1 0 2.50
Maplebear 0 6 14 0 2.70

Raia Drogasil currently has a consensus price target of $5.20, indicating a potential upside of 18.45%. Maplebear has a consensus price target of $58.24, indicating a potential upside of 14.73%. Given Raia Drogasil’s higher possible upside, equities research analysts plainly believe Raia Drogasil is more favorable than Maplebear.

Profitability

This table compares Raia Drogasil and Maplebear’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Raia Drogasil 2.99% 20.12% 5.88%
Maplebear 11.97% 20.19% 14.13%

Earnings and Valuation

This table compares Raia Drogasil and Maplebear”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Raia Drogasil $7.92 billion 0.73 $232.27 million $0.15 29.27
Maplebear $3.99 billion 2.94 $447.00 million $1.83 27.74

Maplebear has lower revenue, but higher earnings than Raia Drogasil. Maplebear is trading at a lower price-to-earnings ratio than Raia Drogasil, indicating that it is currently the more affordable of the two stocks.

Summary

Maplebear beats Raia Drogasil on 11 of the 13 factors compared between the two stocks.

About Raia Drogasil

(Get Free Report)

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

About Maplebear

(Get Free Report)

Maplebear Inc., doing business as Instacart, engages in the provision of online grocery shopping services to households in North America. It sells and delivers grocery products, as well as pickup services through a mobile application and website. It also operates virtual convenience stores; and provides software-as-a-service solutions to retailers. The company was incorporated in 2012 and is based in San Francisco, California.

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.